These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22700811)

  • 1. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
    Runia TF; Hop WC; de Rijke YB; Buljevac D; Hintzen RQ
    Neurology; 2012 Jul; 79(3):261-6. PubMed ID: 22700811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C; Zeng Z; Wang B; Guo S
    J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
    Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
    Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
    Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
    Bhargava P; Steele SU; Waubant E; Revirajan NR; Marcus J; Dembele M; Cassard SD; Hollis BW; Crainiceanu C; Mowry EM
    Mult Scler; 2016 May; 22(6):753-60. PubMed ID: 26286698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
    Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei IA
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
    Ferre' L; Clarelli F; Sferruzza G; Rocca MA; Mascia E; Radaelli M; Sangalli F; Dalla Costa G; Moiola L; Aboulwafa M; Martinelli Boneschi F; Comi G; Filippi M; Martinelli V; Esposito F
    Neurol Sci; 2018 Aug; 39(8):1467-1470. PubMed ID: 29756179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
    Hartl C; Obermeier V; Gerdes LA; Brügel M; von Kries R; Kümpfel T
    J Neurol Sci; 2017 Apr; 375():160-164. PubMed ID: 28320120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
    Runia TF; Neuteboom RF; de Groot CJ; de Rijke YB; Hintzen RQ
    Eur J Neurol; 2015 Mar; 22(3):479-84. PubMed ID: 25430875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M; Airas L; Mononen I; Heikkilä A; Viljanen M; Hänninen A
    Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.
    Saltytė Benth J; Myhr KM; Løken-Amsrud KI; Beiske AG; Bjerve KS; Hovdal H; Midgard R; Holmøy T
    Neuroepidemiology; 2012; 39(2):84-93. PubMed ID: 22814117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
    Cortese M; Munger KL; Martínez-Lapiscina EH; Barro C; Edan G; Freedman MS; Hartung HP; Montalbán X; Foley FW; Penner IK; Hemmer B; Fox EJ; Schippling S; Wicklein EM; Kappos L; Kuhle J; Ascherio A;
    Neurology; 2020 May; 94(18):e1950-e1960. PubMed ID: 32300060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    Mimpen M; Rolf L; Poelmans G; van den Ouweland J; Hupperts R; Damoiseaux J; Smolders J
    PLoS One; 2021; 16(12):e0261097. PubMed ID: 34855907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin A is not associated with exacerbations in multiple sclerosis.
    Runia TF; Hop WC; de Rijke YB; Hintzen RQ
    Mult Scler Relat Disord; 2014 Jan; 3(1):34-9. PubMed ID: 25877971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.